<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00728754</url>
  </required_header>
  <id_info>
    <org_study_id>2301</org_study_id>
    <nct_id>NCT00728754</nct_id>
  </id_info>
  <brief_title>A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.</brief_title>
  <acronym>Cliffhanger</acronym>
  <official_title>A Prospective, Randomized-controlled Multicenter Study of the Osseotite Certain Lateralized Implant in Short-span Fixed Bridge Cases for Preservation of Crestal Bone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized study will evaluate the performance of the Osseotite Certain
      Prevail implant when compared to that of the non-lateralized version of the implant.

      Study (null) hypothesis: the crestal bone changes that take place after placement and loading
      of the Osseotite lateralized implants will be the same as for a similar but non-lateralized
      Osseotite Certain implant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized, longitudinal study in which qualified patients with
      partial edentulism will receive a short-fixed bridge restoration. Each implant site is
      randomized to receive either the Osseotite Certain Lateralized (test) or the Osseotite
      Certain Non-lateralized (control). All implants will receive a temporary prosthesis after two
      months of placement. Enrollment will include up to 20 patients (approximately 60 implants per
      center) at each participating study center.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</measure>
    <time_frame>1 year</time_frame>
    <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osseous Integration</measure>
    <time_frame>four years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Partial Edentulism</condition>
  <condition>Tooth Disease</condition>
  <arm_group>
    <arm_group_label>Dental implant Osseotite Prevail</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dental implant with lateralized design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dental implant Osseotite</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant without the lateralized design</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental implant Osseotite Prevail</intervention_name>
    <description>Root form titanium dental implant</description>
    <arm_group_label>Dental implant Osseotite Prevail</arm_group_label>
    <other_name>Osseotite</other_name>
    <other_name>Prevail</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental implant Osseotite</intervention_name>
    <description>root form titanium dental implant</description>
    <arm_group_label>Dental implant Osseotite</arm_group_label>
    <other_name>Osseotite</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex and any race greater than 18 years of age

          -  patients for whom a decision has already been made to use dental implants for treating
             an existing condition specifically: A partially edentulous short-span fixed case of
             less than 4 implants in the maxilla or mandible; the prosthesis may be anterior,
             posterior, or transitionally anterior-posterior; no cantilevers allowed but one
             interior crown may be a pontic

          -  patients must be physically able to tolerate conventional surgical and restorative
             procedures

          -  patients must agree to be evaluated for each study visit, especially the yearly
             follow-up visits

        Exclusion Criteria:

          -  patients with active infection or severe inflammation in the areas intended for
             implant placement

          -  patients with a &gt;10 cigarette per day smoking habit

          -  patients with uncontrolled diabetes mellitus

          -  patients with metabolic bone disease

          -  patients who have had treatment with therapeutic radiation to the head within the past
             12 months

          -  patients in need of allogenic bone grafting a the site of the intended study implant

          -  patients who are pregnant at the screening visit

          -  patients with evidence of severe para-functional habits such as bruxing or clenching

          -  patients with cantilevers and more than one pontic per bridge
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold Baumgarten, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2008</study_first_submitted>
  <study_first_submitted_qc>August 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2008</study_first_posted>
  <results_first_submitted>June 26, 2009</results_first_submitted>
  <results_first_submitted_qc>October 11, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 17, 2011</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dental implants</keyword>
  <keyword>Osseotite Certain Prevail</keyword>
  <keyword>Lateralized</keyword>
  <keyword>non-lateralized</keyword>
  <keyword>Osseotite Certain</keyword>
  <keyword>multicenter</keyword>
  <keyword>randomized</keyword>
  <keyword>clinical study</keyword>
  <keyword>partial edentulism</keyword>
  <keyword>single stage</keyword>
  <keyword>early loading</keyword>
  <keyword>crestal bone level</keyword>
  <keyword>short fixed bridge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Up to 120 patients were enrolled across all centers, with enrollment efforts beginning in February 2005. Enrollment period remained open until June 2006. Two participating sites were Universities and four were private practices.</recruitment_details>
      <pre_assignment_details>Pre-treatment included a screening visit (enroll those meeting all inclusion criteria), signing informed consent, and pre-surgical data collection.Patients returned for implant placement surgery, followed by temporary prosthesis placement at 2 months.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="P2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the lateralized expanded platform design</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Implant Placement Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29">Individual test implant units is 75</participants>
                <participants group_id="P2" count="32">Individual control implant units is 78</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29">Individual test implant units completed = 75</participants>
                <participants group_id="P2" count="32">Individual control implant units completed = 78</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Permanent Prosthesis Placement</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29">Individual test implant units is 75</participants>
                <participants group_id="P2" count="32">Individual control implant units is 78</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25">Individual test implant units completed = 66</participants>
                <participants group_id="P2" count="28">Individual control implant units completed = 68</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>One Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25">individual test implant units is 66</participants>
                <participants group_id="P2" count="28">individual control implant units is 68</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24">individual test implant units completing is 65</participants>
                <participants group_id="P2" count="28">individual control implant units completed= 68</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Two Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24">individual test implant units is 65</participants>
                <participants group_id="P2" count="28">individual control implant units is 68</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24">individual test implant units completed= 65</participants>
                <participants group_id="P2" count="28">individual test implant units completed= 68</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="B2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the lateralized expanded platform design</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</title>
        <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
        <time_frame>1 year</time_frame>
        <population>population analyzed was all patients receiving implants enrolled in the study, those reported here actually represent the number of implants being followed at the 12 month follow-up time point (time of analysis).</population>
        <group_list>
          <group group_id="O1">
            <title>Osseotite Certain Prevail Implant</title>
            <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
          </group>
          <group group_id="O2">
            <title>Osseotite Certain Implant</title>
            <description>Patients with dental implant with internal connection and without the lateralized expanded platform design</description>
          </group>
        </group_list>
        <measure>
          <title>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</title>
          <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
          <population>population analyzed was all patients receiving implants enrolled in the study, those reported here actually represent the number of implants being followed at the 12 month follow-up time point (time of analysis).</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7440" spread="0.1881"/>
                    <measurement group_id="O2" value="-0.8445" spread="0.1439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Osseous Integration</title>
        <time_frame>four years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events are collected and reported from day 1 of the study to present, 4 years of study duration to date.</time_frame>
      <desc>Adverse event data is collected by patient questioning and visual examination of patient's mouth each study event visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="E2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the lateralized expanded platform design</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="29"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Loss of integration of implant</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="29"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Manager</name_or_title>
      <organization>Biomet 3i LLC</organization>
      <phone>5617766722</phone>
      <email>cristina.matthews@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

